NEW YORK, May 4, 2011 /PRNewswire/ -- Robotic prostatectomy and prostate cancer treatment expert Dr. David B. Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, appeared on FOX-NY's Good Day New York to discuss the successes of robotic surgery in prostate cancer treatment, and the benefits it has over other treatment options, making robotic surgery a preferential method for prostate cancer treatment.
When choosing a robotic prostatectomy as a first line of defense against organ confined prostate cancer, the odds of a cancer cure with minimal post operative complications are in the patient's favor, according to data gathered from Mount Sinai's robotic surgery program.
In the event of the recurrence of cancer, radiation can then be used as an additional tool to treat the patient. "If a patient is first treated with radiation, and the prostate cancer returns, it's extremely difficult to follow-up with a successful prostate surgery, known as a salvage robotic prostatectomy, unless the surgeon is very skilled in the technique. The incidences of incontinence, as well as impotence, are extremely high after prostate surgery under this scenario. I see low dose radiation as a supplemental tool to robotic surgery. It's useful in treating recurring cancer after a prostatectomy, which is unlikely to occur based on my surgical experience, particularly with the SMART Surgery Technique," said Samadi.